UNeMed Corporation
AI Summary
UNeMed Corporation, with EIN 82-2026061, is a nonprofit organization dedicated to improving healthcare through the promotion of innovation and the advancement of biomedical research, while actively engaging entrepreneurs and industry partners to commercialize novel technologies. With an operating budget of $3.7 million and total revenue of $3.8 million for the 2025 filing year, UNeMed supports initiatives in the education and health sectors. More information can be found on their website at www.unemed.com.
Was this helpful?
This summary is AI-generated from ChatGPT. It’s meant to be helpful, but isn’t always perfect.
Mission Statement
UNeMed Corporation's mission is to improve healthcare by fostering innovation, advancing biomedical research, and engaging entrepreneurs and industry to commercialize novel technologies.
Cause Areas
2
Health
Education
Explore this org's ecosystem
See similar nonprofits by cause and location, their funders, and their grants.
Learn about Ecosystems


Explore this org's ecosystem
See similar nonprofits by cause and location, their funders, and their grants.
Learn about Ecosystems
Charity Verification Snapshot
IRS EO Business Master File Status
Listed as tax-exempt
IRS Pub 78 Status
Eligible for tax-deductible gifts
IRS Revocation Status
Not in Automatic Revocation of Exemption List
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Learn about Due Diligence


Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Learn about Due Diligence
Frequently Asked Questions
What is UNeMed Corporation’s budget?
In 2025, UNeMed Corporation reported an annual operating budget of around $3.7 million. More detailed financial information is available to registered users.
What causes does UNeMed Corporation support?
UNeMed Corporation supports work in Health and Education.
Where does UNeMed Corporation operate?
UNeMed Corporation is headquartered in Omaha, NE.
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)